Initially, HNSCC patients were divided into ‘High’ and ‘Low’ IL-6/IL-6R groups based on RNA-Seq data from TCGA, where the expression of both genes either fell in the upper third or in the lower third (see methods). This evidence concerns the gene IL6R and head and neck squamous cell carcinoma.